15 December 2020

Conditions COVID-19 Telehealth

How rheumatology changed in 2020

15 December 2020

Cognitive Therapies Osteoarthritis Spondyloarthritis

News bites: New treatment for scleroderma?

14 December 2020

Conditions Technology Telehealth

A tech-tonic shift in healthcare

14 December 2020

Conditions Diet Obesity Polymyalgia Rheumatica

Non-drug options to avoid gout

3 December 2020

Medications

Patients lose choice of assessor in NDIS reforms

3 December 2020

Analgesics Conditions Spondyloarthritis

Battle of the monotherapies: etanercept vs methotrexate

3 December 2020

Analgesics Conditions Lupus

Ixekizumab PBS-subsidised for AS

3 December 2020

Ankylosing Spondylitis Biologics Corticosteroids Juvenile Arthritis Medications

‘Absolutely invaluable’, ‘Big-Brother like’: ARA initiative sparks controversy

18 November 2020

DMARDS

Oz’s first wellness officer is a rheumatologist

12 November 2020

NSAIDS

‘Sophisticated eskies’ will keep COVID vax chill

12 November 2020

Polymyalgia Rheumatica

Febuxostat as safe as allopurinol in FAST study

12 November 2020

Biologics Conditions

Even low-dose glucocorticoids have risks

12 November 2020

Ankylosing Spondylitis Communicable Diseases Corticosteroids Gout NDIA Scleroderma Spondyloarthritis

Some RA patients stuck in a drug switch cycle

12 November 2020

Systemic vasculitis Women

Thalidomide survivors – Where are they now?

4 November 2020

Analgesics Conditions Pharmacy Guild of Australia

COVID or giant cell arteritis: how to spot the difference

4 November 2020

Analgesics Conditions Pain

Post-surgery pain and trusting biosimilars